Juan R. Del Valle - CV
Juan R. Del Valle, Ph.D.
Curriculum Vitae
March 5, 2016
CURRENT POSITION
Associate ProfessorTel: (813) 974-7306
Department of ChemistryFax:(813) 974-3203
University of South FloridaEmail:
4202 East Fowler Avenue, CHE205Web: delvallelab.weebly.com
Tampa, FL 33620
EDUCATION
1999-2004Ph.D. in Organic Chemistry; University of California at San Diego
1995-1999B.A. in Chemistry; Carleton College
POSTGRADUATE TRAINING
2004-2006Postdoctoral Fellowship in Bioorganic Chemistry,Université de Montréal
EMPLOYMENT AND ACADEMIC APPOINTMENTS
2015-presentAssociate Professor, Department of Chemistry,
University of South Florida
2009-2015Assistant Professor, Chemical Biology & Molecular Medicine Program
H. Lee Moffitt Cancer Center & Research Institute
2009-2015Affiliate Assistant Professor, Department of Chemistry,
University of South Florida
2006-2008Assistant Professor, Department of Chemistry and Biochemistry,
New Mexico State University
2004-2006Postdoctoral Fellow, Department of Chemistry,
Universityof Montreal (PI: Stephen Hanessian)
1999-2004Graduate Research Associate, Department of Chemistry and Biochemistry,
University of California at San Diego (PI: Murray Goodman)
1998REU Fellow, Department of Pharmaceutical Chemistry,
University of Utah (PI: Bradley Anderson)
RESEARCH INTERESTS
Peptidomimetics; Inhibitors of protein-protein interactions; Natural product synthesis; Peptide folding;Constrained amino acids;Structure-based drug design
PUBLICATIONS (underline denotes corresponding authorship)
33.Del Valle JR. Heterocyclic extended dipeptide surrogates for beta-strand stabilization. Top. Heterocycl. Chem. (2016), In press.
32.Tang CA, Zundell JA, Ranatunga S, Lin C, Nefedova Y, Del Valle JR, Hu CA. Agonist-mediated activation of STING induces apoptosis in malignant cells. Cancer Res.(2016),In press.
31.Kang C, Sarnowski MP, Ranatunga S, Wojtas L, Metcalf RD, Guida WC, Del Valle JR.Beta-strand mimics based on tetrahydropyridazinedione (tpd) peptide stitching. Chem. Comm. (2015), 15, 16259.
30.Kang C, Ranatunga S, Sarnowski MP, Del Valle JR. Solid-phase synthesis of tetrahydropyridazinedione-constrained peptides. Org. Lett. (2014), 16, 5434.
29.Kim YB, Kang CW, Ranatunga S, Yang H, Sebti SM, Del Valle JR. Imidazo[1,2-a]pyridine-based peptidomimetics as inhibitors of Akt. Bioorg. Med. Chem. Lett. (2014) 24, 4650.
28.Ranatunga S, Tang CA, Kang C, Kloppenburg B, Kriss CL, Hu CA, Del Valle JR. Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. J. Med. Chem. (2014)57, 4289.
** Highlighted in SciBx ‘This Week in Therapeutics’DOI: 10.1038/scibx.2014.702**
27.Tang, CA, Ranatunga S, Kriss, CL, Cubbitt CL, Pinilla-Ibarz JA, Del Valle JR, Hu CA. Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J. Clin. Inv. (2014) 124, 2585.
** Highlighted in Cancer Discovery ‘Research Watch’DOI: 10.1158/2159-8290.CD-RW2014-114**
** Highlighted in SciBx ‘This Week in Therapeutics’ DOI: 10.1038/scibx.2014.702**
26.Dorich S, Del Valle JR, Hanessian S. Synthesis of functionalized octahydroindoles related to daphnyphyllum alkaloids. Synlett (2014) 25, 799-804.
25.Del Valle JR, Thierren E, Hanessian S. Aeruginosins as thrombin inhibitors. In Natural Products in Medicinal Chemistry, Vol. 60: Wiley-VCH; 2013. p. 333-56.
24.Kang C, Sun Y, Del Valle JR. Substituted imidazo[1,2-a]pyridines as beta-strand peptidomimetics. Org. Lett. (2012) 14, 6162-5.
23. Ranatunga S, Tang CA, Hu CA, Del Valle JR. Total synthesis and structural confirmation of lucentamycin A. J. Org. Chem. (2012) 77, 9859-64.
22. Cha JW, Park JS, Sim T, N SJ, Kwon HC, Del Valle JR, Fenical W. Structure assignment of lucentamycin E and revision of the olefin geometries of the marine-derived lucentamycins. J. Nat. Prod. (2012) 75, 1648.
21.Kim YB, Balasis ME, Doi K, Berndt N, DuBoulay C, Hu CC, Guida W, Wang HG, Sebti SM, Del Valle JR. Synthesis and evaluation of substituted hexahydronaphthalene derivatives as novel inhibitors of the Mcl-1/BimBH3 interaction. Bioorg. Med. Chem. Lett. (2012) 22, 5961-5.
20. Kriss CL, Pinilla-Ibarz JA, Mallioux A, Powers JJ, Tang CA, Kang C, Zanesi N, Epling-Burnette PK, Sotomayor EM, Croce CM, Del Valle JR, Hu, CA. Overexpression of TCL1 activates endoplasmic reticulum stress response: A novel mechanism of leukemic progression in mice. Blood (2012) 120, 1027-1038.
19.Ranatunga S, Kim JS, Pal U, Del Valle JR. An Ester Enolate-Claisen Rearrangement Route to Substituted 4-Alkylideneprolines. Studies toward a Definitive Structural Revision of Lucentamycin A. J. Org. Chem. (2011) 76, 8962-76.
** Selected for ACS ‘Virtual Issue on Peptide Chemistry’. **
18.Ranatunga S, Del Valle JR. Synthesis of GSK3-Mimetic Inhibitors of Akt Featuring a Novel Extended Dipeptide Surrogate. Bioorg. Med. Chem. Lett. (2011) 21, 7166-9.
17.Kim YB, Del Valle JR. Synthesis of a diversifiable cis-dehydrodecalin scaffold based on meiogynin A. Tetrahedron Lett. (2011) 52, 6396-8.
16.Hanessian S, Vakiti RR, Dorich S, Banerjee S, Lecomte F, Del Valle JR, Zhang J, Deschenes-Simard B. Total synthesis of pactamycin. Angew. Chem. Int .Ed. (2011) 50, 3497-500.
15.Ranatunga S, Liyanage W, Del Valle JR. Synthesis and conformational analysis of bicyclic extended dipeptide surrogates. J. Org. Chem. (2010) 75, 5113-25. PMCID: 2914495.
14.Ranatunga S, Del Valle JR. Synthesis of Boc-protected bicycloproline. Tetrahedron Lett. (2009) 50, 2464-6.
13.Pal U, Ranatunga S, Ariyarathna Y, Del Valle JR. Total synthesis of the putative structure of lucentamycin A. Org. Lett. (2009) 11, 5298-301.
12.Hanessian S, Wang X, Ersmark K, Del Valle JR, Klegraf E. Total synthesis and structural revision of the presumed aeruginosins 205A and B. Org. Lett. (2009) 11, 4232-5.
11.Del Valle JR, Wang X, Ersmark K, Hanessian S. Beta-substituted D-leucines and their relevance in the total synthesis of natural and unnatural aeruginosins. In Asymmetric Synthesis and Application of alpha-Amino Acids: American Chemical Society; 2009. p. 443-61.
10.Liyanage W, Weerasinghe L, Strong RK, Del Valle JR. Synthesis of carbapyochelins via diastereoselective azidation of 5-(ethoxycarbonyl)methylproline derivatives. J. Org. Chem. (2008) 73, 7420-3.
9.Ersmark K, Del Valle JR, Hanessian S. Chemistry and biology of the aeruginosin family of serine protease inhibitors. Angew. Chem. Int. Ed. (2008) 47, 1202-23.
8.Hanessian S, Ersmark K, Wang X, Del Valle JR, Blomberg N, Xue Y. Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombin. Bioorg. Med. Chem. Lett. (2007) 17, 3480-5.
7. Hanessian S, Del Valle JR, Xue Y, Blomberg, N. Total synthesis and structural confirmation of chlorodysinosin A. J. Am. Chem. Soc. (2006) 128, 10491-5.
6.Zapf CW, Del Valle JR, Goodman M. Utilizing the intramolecular Fukuyama-Mitsunobu reaction for a flexible synthesis of novel heterocyclic scaffolds for peptidomimetic drug design. Bioorg. Med. Chem. Lett. (2005) 15, 4033-6.
5.Hanessian S, Tremblay M, Marzi M, Del Valle JR. Synthetic studies in the intramolecular carbocyclization of N-acyloxyiminium ions. Stereoelectronic and steric implications of nucleophilic alkene, alkyne, and allene tethers. J. Org. Chem. (2005) 70, 5070-85.
4.Del Valle JR, Goodman M. An efficient RCM-based synthesis of orthogonally protected meso-DAP and FK565. J. Org. Chem. (2004) 69, 8946-8.
3.Del Valle JR, Goodman M. Asymmetric hydrogenations for the synthesis of Boc-protected 4-alkylprolinols and prolines. J. Org. Chem. (2003) 68, 3923-31.
2.Del Valle JR, Goodman M. Stereoselective synthesis of Boc-protected cis and trans-4-trifluoromethylprolines by asymmetric hydrogenation reactions. Angew. Chem. Int. Ed. (2002) 41, 1600-2.
1.Goodman M, Del Valle JR, Amino Y, Benedetti E. Molecular basis of sweet taste in dipeptide taste ligands. Pure Appl. Chem. (2002) 74, 1109-16.
PATENTS
Del Valle JR, Hu CA. Inhibitors of the IRE-1/XBP-1 pathway and methods of using thereof. PCT Int. Appl. (2014) WO 2014176348.
CONFERENCE ABSTRACTS/POSTERS
21. Ranatunga S, Tang CA, Kang C, Kloppenburg B, Kriss CL, Hu CA, Del Valle JR. Novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. Moffitt Scientific Symposium, Tampa, May 2014.
20.Kang C, Sun Y, Del Valle JR. IP-tides: Imidazo[1,2-a]pyridine-based peptidomimetics. American Peptide Society Symposium, Waikaloa, June 2013.
19. Ranatunga S, Del Valle JR. Total synthesis and structural revision of lucentamycin A. American Peptide Society Symposium, Waikaloa, June 2013.
18. Ranatunga S, Del Valle JR. Design and synthesis of novel macrocyclic beta-strand orthotics. American Peptide Society Symposium, Waikaloa, June 2013.
17. Kim YB, Kang C, Yang, Sebti SM, Del Valle JR. Peptidomimetic inhibitors of Akt and SGK targeting the substrate binding domain. American Peptide Society Symposium, Waikaloa, June 2013.
16.Kim YB, Kang C, Ranatunga S, Yang, Sebti SM, Del Valle JR. Design and synthesis of substrate-mimetic Akt inhibitors based on the structure of GSK3beta. Moffitt Scientific Symposium, Tampa, FL, May 2013.
15.Kim YB, Balasis ME, DuBoulay C, Wang HG, Sebti SM Guida W, Hu CA, Del Valle JR. Synthesis of hexahydronaphthalene derivatives and their biological evaluation as Mcl-1 antagonists. Gordon Research Conference Bioorganic Chemistry, Andover, NH, June 2012.
14. Kim YB, Balasis ME, DuBoulay C, Wang HG, Sebti SM Guida W, Hu CA, Del Valle JR. Synthesis of hexahydronaphthalene derivatives and their biological evaluation as Mcl-1 antagonists. Moffitt Scientific Symposium, Tampa, May 2012.
13.Ranatunga S, Del Valle JR.Synthesis of Novel Extended Dipeptide Surrogates and their Incorporation into Peptidomimetic Inhibitors of Akt. National Meeting of the American Peptide Society, San Diego, June 2011.
12.Ranatunga S, Kim JS, Del Valle JR. Synthetic Studies Toward Lucentamycin A and 3-Alkyl-4-Alkylideneprolines via Ester Enolate-Claisen Rearrangement. National Meeting of the American Peptide Society, San Diego, June 2011.
11.Ranatunga S, Kim JS, Del Valle JR. Exploring an Ester Enolate-Claisen Rearrangement Route toLucentamycin A and Related 3-Alkyl-4-Alkylideneprolines. 87th ACS FAME Conference, Palm Harbor, Florida,May 2011.
10.Ranatunga S, Kim JS, Del Valle JR. Exploring an Ester Enolate-Claisen Rearrangement Route toLucentamycin A and Related 3-Alkyl-4-Alkylideneprolines. 9th Annual Castle Conference, Tampa, April 2011.
9.Ranatunga S, Pal U, Del Valle JR. Synthetic Studies Toward the Cytotoxic Marine Tripeptide Lucentamycin A. National Meeting of the American Chemical, Boston, MA, August 2010
8.Ranatunga S, Yang H, Sebti S, Del Valle JR. Synthesis of Akt Inhibitors Using a Bicyclic Proline-Based Scaffold as the Peptidomimetic Core. 8th Annual Castle Conference, Tampa, FL, April 2010.
7.Ranatunga S, Yang H, Sebti S, Del Valle JR. Synthesis of Akt Inhibitors Using a Bicyclic Proline-Based Scaffold as the Peptidomimetic Core. Moffitt Symposium, Tampa, FL, March 2010.
6.Ranatunga S, Del Valle JR. Synthesis of Extended Dipeptide Surrogates for Akt Inhibitor Design. FCoE-BITT Symposium on Drug Design, Discovery, and Delivery, Tampa, FL, October 2009.
5.Liyanage W, Del Valle JR. Reactions of -Proline Enolates for the Synthesis of Constrained Peptidomimetics. National Meeting of the American Peptide Society, Bloomington, June 2009.
4.Del Valle JR. Total Synthesis and Structural Confirmation of Chlorodysinosin A. Quebec-Ontario Symposium of Bioorganic Chemistry, St. Adéle, November 2005.
3.Del Valle JR, Goodman M. Asymmetric Hydrogenations for the Synthesis of 4-Alkylprolines. National Meeting of the American Peptide Society, Boston, April 2003.
2. Kwak J, Del Valle JR, Goodman M. Collagen Mimetics Incorporating Hydroxyproline and Fluoroproline Guest Residues. National Meeting of the American Peptide Society, San Diego, June 2001.
1.Del Valle JR, Goodman M. Synthesis of Novel Fluorinated Building Blocks for Peptidomimetic Drug Design. National Meeting of the American Chemical Society, San Diego, April 2001.
RESEARCH SUPPORT
Active Grants
Pharmacological blockade of XBP-1s expression in cancer
Grant #:1R01CA190860-01
PI:Del Valle JR, Hu CA (MPI)
Dates:9/14/15 – 08/31/20
Source:NIH/NCI
Role: Principal Investigator and Contact PI
Direct Costs:$2,019,070
Total Award:$2,280,664
Optimization and efficacy of covalent IRE-1 RNase inhibitors in CLL
Grant #:1R21CA195894-01
PI:Del Valle JR
Dates:9/07/15 – 08/31/20
Source:NIH/NCI
Role: Principal Investigator
Direct Costs:$283,154
Total Award:$395,091
Targeting antigen-induced ER stress response in B-cell chronic lymphocytic leukemia
Grant #:1R01CA163910-01A1
PI:Hu, CA
Dates:9/13 – 06/18
Source:NIH/NCI
Role: Co-Investigator
Direct Costs:$1,037,500
Total Award:$1,748,188
Completed Grants
Targeting Akt with substrate-mimetic antagonists
Grant #:5R21CA167215
PI:Del Valle JR
Dates:9/12 – 08/15
Source:NIH/NCI
Role: Principal Investigator
Direct Costs:$239,250
Total Award:$403,137
Chemical and biological studies of marine-derived non-ribosomal peptides
Grant #:1BN03
PI:Del Valle JR
Source:Bankhead Coley Research Program (FL DOH)
Role: Principal Investigator
Direct Costs:$347,825
Total Award:$400,000
Natural product-inspired approaches targeting Mcl-1
Grant #:1KN03
PI:Del Valle JR
Source:James & Esther King Biomedical Research Program (FL DOH)
Role: Principal Investigator
Direct Costs:$347,825
Total Award:$400,000
Synthetic methods toward antimicrobial tert-alkylamino carbocycles
Grant #:SC2AI081526
PI:Del Valle JR
Source:NIH/NIAID
Role: Principal Investigator
Direct Costs:$200,00
Total Award:$282,800
Synthesis of functional probes for siderocalin-induced apoptosis
Grant #:IRG9309214
PI:Pledger WJ
Source:American Cancer Society
Role: Project Leader
Direct Costs:$30,000
Total Award:$30,000
Probing novel mechanisms to target kinases for cancer drug discovery
Grant #:n/a
PI:Sebti SM
Source:Anna Valentine Cancer Fund FIG (Internal)
Role: Project Leader
Direct Costs:$75,000
Total Award:$75,000
Synthesis of new ligands for the characterization of siderophore-ExFABP interactions
Grant #:U54CA132383
PI:O’Connell M
Source:NIH/NCI
Role: Project Leader
Direct Costs:$245,066
Total Award:$345,317
INVITED TALKS AND ORAL PRESENTATIONS
10/2015University of Texas at Dallas, Dept. of Chemistry& Biochemistry
Novel peptide orthotics for -strand mimicry
03/2015University of Pennsylvania, Dept. of Chemistry
Novel peptide orthotics for -strand mimicry
03/2015249th American Chemical Society National Meeting, Denver, CO
Constrained N-amino peptide derivatives for conformational scanning applications
03/2015249th American Chemical Society National Meeting, Denver, CO
Small-molecules targeting XBP-1s expression in cancer
03/201516th Florida Heterocyclic and Synthetic Conference, Gainesville, FL
Synthesis of -strand orthotics for peptide conformational scanning
01/2015Wistar Institute, Molecular & Cellular Oncogenesis Program
Unconventional approaches toward kinase inhibition
01/2015Purdue University, Dept. of Medicinal Chemistry and Mol. Pharm.
Unconventional approaches toward kinase inhibition
12/2014University of Utah, Dept. of Medicinal Chemistry
Small-molecules targeting XBP-1s expression in cancer
11/2014University of South Florida, Dept. of Molecular Medicine
Small-molecules targeting XBP-1s expression in cancer
06/201497thCanadian Society for Chemistry National Meeting, Vancouver, BC
Synthesis of novel peptide orthotics for bioactive -strands
05/2014University of New Mexico Cancer Center, Center of Molecular Discovery
Small-molecules targeting XBP-1s expression in cancer
05/2014University of Denver, Dept. of Chemistry and Biochemistry
Synthesis of novel peptide orthotics for bioactive -strands
02/2014University of Florida, Department of Medicinal Chemistry
Unconventional approaches toward kinase inhibition
02/2014University of New Mexico, Dept. of Chemistry and Chemical Biology
Unconventional approaches toward kinase inhibition
05/2013Florida Annual Meeting of theAmerican Chemical Society, Palm Harbor, FL
New strategies for mimicry of biologically active -strands
11/2012Southeastern Regional Meeting of the American Chemical Society, Raleigh, NC
Synthetic studies toward the cytotoxic marine peptide lucentamycin A
08/2008Fred Hutchinson Cancer Research Center, Division of Basic Science
Elucidating the function of siderocalins using small molecule chemical probes
11/2007New Mexico Institute of Mining and Technology, Dept. of Chemistry
Total synthesis of chlorodysinosin A and development of azonia-Prins cyclizations
HONORS AND AWARDS
2010CIBA Young Scientist Award, awarded by the CIBA Foundation and ACS YCC
2010Milestone Award, awarded by the Miles for Moffitt Foundation
2004Teddy Traylor Award for graduate research, awarded by the University of California at San Diego
2004Exemplary Teaching Assistant Performance Award, awarded by the University of California at San Diego
2002American Peptide Society Travel Award
1999-2001San Diego Fellowship, awarded by the University of California at San Diego
1998REU Fellowship, University of Utah
TEACHING EXPERIENCE
Courses Taught
2016 (Fall)Organic Chemistry II (CHM 2211, USF), Course Instructor
2016 (Spring)Organic Chemistry II (CHM 2211, USF), Course Instructor
2014Bioethics (PCB 6932, MCC), Lecturer
2014Cancer Biology III (PCB 6205, MCC), Lecturer
2012-2013Cancer Biology I (PCB 6230, MCC), Lecturer
2011-2014Introduction to Medicinal Chemistry (CHEM 4932/6938, USF), Lecturer
2009-2012Drug Discovery Colloquium (CHEM 6936, USF), Lecturer
2006-2009Organic Chemistry I (CHEM 313, NMSU), Course Instructor
2006-2009Advanced Organic Chemistry (CHEM 466/515, NMSU),Course Instructor
Undergraduate Mentoring
2016International Undergraduate Research Mentor for Bomi Kim
2008-2009MARC (Minority Access to Research Careers) Mentor for Leticia A. Montoya
2007Undergraduate Research Mentor for Christian Talamantes
2006Undergraduate Research Mentor for Lee Uranga
Graduate Mentoring
2015-presentPh.D. Graduate Student Advisor for Yassin El-Batrawi
2014-presentPh.D. Graduate Student Advisor for Matthew Sarnowski
2006-2012Ph.D. Graduate Student Advisor for Sujeewa R. Mahanthe Mudiyanselage
2006-2009M.S. Graduate Student Advisorfor Wathsala Liyanage
Postdoctoral Mentoring
2016-presentJustin Goodwin, Ph.D.
2010-presentChang Won Kang, Ph.D.
2012-2015Sujeewa Ranatunga, Ph.D.
2009-2013Young B. Kim, Ph.D.
2010-2012Yongmao Sun, Ph.D.
2009-2011Jinsoo Kim, Ph.D.
2008-2009Ujjwal Pal, Ph.D.
Student Advising
2016M.S. Thesis Committee, Jeanine Yacoub, Member
Ph.D. Thesis Committee, Yi Liang, Member
Ph.D. Candidacy Committee, Lulu Wei, Member
2015Ph.D. Candidacy Committee, Santana Thomas, Member
Ph.D. Candidacy Committee, Andrea Lemus, Member
Ph.D. Candidacy Committee, Dan Utic, Member
2014Ph.D. Thesis Committee, Brent Kuenzi, Member
2012Ph.D. Thesis Committee, Sujeewa Mudiyanselage, Chair
2012Ph.D. Thesis Committee, Hyun Joo Kil, Member
2012Ph.D. Thesis Committee, Courtney DeBoulay, Member
2009M.S. Thesis Committee, Wathsala Liyanage, Chair
2009Comprehensive Exam Committee, Sujeewa Mudiyanselage, Chair
2008Ph.D. Thesis Committee, Kris Waynant, Member
2008Comprehensive Exam Committee, Sarah Gibson, Member
2008M.S. Thesis Committee, Jon Shirley, Member
2008Comprehensive Exam Committee, Paul Wiget, Member
2007Comprehensive Exam Committee, Kris Waynant, Member
2007Comprehensive Exam Committee, Ritwik Burai, Member
2007Ph.D. Thesis Committee, Shaofeng Duan, Member
2006M.S. Thesis Committee, Jennifer Bell, Member
2006Ph.D. Thesis Committee, Jacob Strousse, Member
SERVICE
Professional Service
2015-presentCouncil Member and Secretary, American Peptide Society
2015Session Chair, 24th American Peptide Society Symposium
2014NIH/NCI Ad Hoc Reviewer, DMP Study Section
2013-2015Member, Nominating Committee, American Peptide Society
2013Session Chair, 23rd American Peptide Society Symposium
2013NIH Early Career Reviewer, SBCBStudy Section
2013NIH/NCI Ad Hoc Reviewer, Developmental Cancer Therapeutics
2011-presentCo-Chair, Student Affairs Committee, American Peptide Society
2006-presentReviewer of submitted manuscripts for the following publications:
Journal of the American Chemical Society, Journal of Organic Chemistry, Organic Letters, Tetrahedron, Tetrahedron Letters, Chemical Communications, European Journal of Medicinal Chemistry, Bioorganic Medicinal Chemistry, Bioorganic Medicinal Chemistry Letters, PLoS One
2012NIH/NCI Ad Hoc Reviewer, Anticancer Therapeutics Topic 255 SBIR Panel
2011NIH/NCI Ad Hoc Reviewer, Anticancer Therapeutics Topic 255 SBIR Panel
2008NSF Ad Hoc Reviewer, CRIF-MU Special Emphasis Panel
Institutional Committees
2015-presentInstrument Committee
2015-presentPeptide/Mass Spec Advisory Committee
2015-presentNMR Advisory Committee
2013-2015Research Value Analysis Committee
2013-2015Chemical Biology Advisory Committee
2011-2013Institutional Product Evaluation Committee
2011-2013Research Product Evaluation Committee
2012ACS Internal Research Grant Review Committee
2012OTMC Internship Program Review Committee
2009-2010Investigator Webpage Committee
2006-2009Stockroom Safety Committee
2006-2009Chem Club Committee
Community Outreach
2015Travel Award Judge, 24th American Peptide Society Symposium, Orlando, FL
2014Faculty Judge, 12th Annual Castle Conference, Tampa, FL
2013Travel Award Judge, 23rdAmerican Peptide Society Symposium, Waikaloa, HI
2011Faculty Judge, 22ndAmerican Peptide Society Symposium, San Diego, CA
2011Travel Award Judge, 22ndAmerican Peptide Society Symposium, San Diego, CA
2010Faculty Judge, 8th Annual Castle Conference, Tampa, FL
2009Faculty Judge, American Peptide Society Symposium, Bloomington, IN
2007Volunteer, Regional Chemical Olympics Competition, Las Cruces, NM
2007Faculty Judge, New Mexico Tech Senior Thesis Symposium, Socorro, NM
PROFESSIONAL ASSOCIATIONS
2009-presentAmerican Association for Cancer Research, Member
2006-presentAmerican Association for the Advancement of Science, Member
2001-presentAmerican Peptide Society, Member
1999-presentAmerican Chemical Society, Member
Page 1 of 10